CLOSE
WEBSITE OF THE STATE OF SOUTH DAKOTA DEPARTMENT OF HEALTH
Kim Malsam-Rysdon, Secretary of Health

South Dakota Board of Pharmacy

Newsletter

 


 

January 2016
South Dakota State Board of Pharmacy
3701 West 49th Street - Suite 204, Sioux Falls, SD 57106
 

BOARD WELCOMES NEW REGISTERED PHARMACISTS/PHARMACIES

     The following candidates recently met licensure requirements and were registered as pharmacists in South Dakota in the last quarter:  Alyssa Brunner, James Burzynski, Annette English, David Farber, Kimberly Faucett, Diane Fox, Rebecca Karg, Angela Le, Adam Manoucheri, Michael Meekins, Patricia Morrical, Michelle Phipps, Syed Saleem, Roxane Skiles, Zachary Thompson, and Curtis Waldvogel.  New pharmacy permits issued over the same time period are: Avera Queen of Peace dba Avera Grassland – Mitchell; CSRX Inc. dba Rushmore Compounding Pharmacy – Rapid City; Lewis Drug #37– Elk Point (change of ownership); Philip Health Services – Philip (change to Telepharmacy); Roger’s Family Pharmacy – Yankton  (change of ownership), Avera McKennan Pharmacy East Campus – Sioux Falls (AMDD); and PharMerica, Luther Manor – Sioux Falls (AMDD).

 

HOW MANY LICENSES DOES BOARD ISSUE IN A YEAR?

     This is a question we get while speaking to others and they are generally surprised at our volume.

Pharmacists – 1932
Pharmacy Interns – 322
Full Time Pharmacy Permits - 273  
Part Time Pharmacy Permits – 46

Pharmacy Technicians – 1480

Wholesale Permits - 1160

Non-Resident Pharmacies – 734

Total - 5,947 Licenses/Registrations

BOARD WELCOMES NEW STAFF

     Beth Windschitl has been hired in the full time Senior Secretary role in our office and she is a very quick study.  Kari Shanard-Koenders, R.Ph. accepted the Executive Director position for the Board office.  Feel free to reach out to any of the Board office staff  if you have needs.  The PDMP Director position remains vacant.

 

ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES (EPCS)

     The board staff continues to receive multiple calls and questions pertaining to EPCS.  An article was published in the April 2015 Newsletter, but a few items probably bear repeating. 

  • Of late, most of the concern is how a pharmacist knows if a prescriber has acquired appropriate approval to conduct this activity.  While the Board staff do not claim to be software experts, we have witnessed feedback mechanisms from software which provides the logic to authenticate the process.  Excellent Q&A on this topic can be found on the DEA website: http://www.deadiversion.usdoj.gov/ecomm/e_rx/faq/pharmacies.htm

  • With EPCS, some providers thought they could now issue multiple CII prescriptions for a total of up to a 120 day supply.  This is not true!  The providers may only issue multiple CII prescriptions for a total of up to a 90 day supply.  The DEA Code of Federal Regulations 1306.12 Refilling prescriptions: issuance of multiple prescriptions addresses this.  Furthermore, the DEA provided the following response:

“In fact, Title 21 CFR 1306.08 (a)(1) specifically states that a practitioner may e-prescribe but only as long as they comply with all other requirements for issuing controlled substance prescriptions.  Further, Title 21 CFR 1311.100 (b)(3) states a practitioner may issue an e-prescription if the prescription is otherwise in conformity with the requirements of the Act and this chapter.  

For pharmacies, Title 21 CFR 1306.08 (b), states a pharmacy may fill an electronic prescription but only if it complies will all other requirements for a controlled substance prescription. [Title 21 CFR 1311.100(e)(2) states the pharmacy can fill it the e-prescription is otherwise in conformity with the requirements of the Act and this chapter.”

  • With EPCS, is there anything that states that the address must be a physical address vs a PO Box?  DEA provided this response “There is nothing in federal regulations that make a distinction between a physical address and PO Box.  It simply requests an “address of the patient” and “address is not defined.”

HOW DOES AN AMBULANCE SERVICE OBTAIN MORPHINE OR OTHER CII CONTROL SUBSTANCES FOR STOCK?

     They would need to obtain it via a DEA-222 Form.  Usually the Medical Director for the Ambulance would be responsible for this.  The Ambulance service needs to obtain a DEA number in collaboration with their Medical Director.

 

PRESCRIPTION DRUG MONITORING PROGRAM UPDATE

     The SD PDMP is working well with the change to Appriss.  Ease of use is a key with PMP AWARxE and we feel that has translated into increased use.  At the end of November, 84% of pharmacists, 25% of MD/DO’s, 52% of PA’s, 43% of NP’s and 20% of dentists are approved for data access.    The top controlled substance in SD remains Hydrocodone combination products despite moving them to CII.  

 

 

     The SD Veterans Affairs facilities have begun reporting again.  The only dispensing entity not reporting to the SD PDMP is Ellsworth AFB.  Appriss has begun including Morphine Milligram Equivalents per prescription to the PDMP Reports as well as an aggregate of the numbers of Prescriptions, Prescribers, Pharmacies and Private Pay transactions for each person queried.

 

HOW DID HYDROCODONE COMBINATION PRODUCTS CII TRANSITION AFFECT PRESCRIBING?

     Lauren M. Kuschel, a P4 Pharm D student and Jane R. Mort, Pharm D, Professor at the SDSU College of Pharmacy conducted data analysis on opioid prescribing patterns by comparing six months prior to Hydrocodone Combination Products (HCP) moving to Schedule II, six months during the transition period (refills allowed) and six months after the conclusion of the transition period, the final period.  They concluded that the number of prescriptions decreased as compared to prior to the transition, but the quantity per Rx increased.  Also other opioid prescribing increased. 

 

 

BOARD MEETING DATES

      Please check our website for the time, location and agenda for future Board meetings.        

BOARD OF PHARMACY STAFF DIRECTORY

Office Phone    605-362-2737 FAX    605-362-2738

Kari Shanard-Koenders, Executive
Director /Interim PDMP Director                                             

kari.shanard-koenders@state.sd.us
Gary Karel, Pharmacy Inspector     gary.karel@state.sd.us
Paula Stotz, Pharmacy Inspector     paula.stotz@state.sd.us
Bill Vander Aarde, Pharmacy  Inspector  Please contact Board office
Melanie Houg,PDMP Assistant    melanie.houg@state.sd.us
Jessica Neal, Secretary   jessica.neal@state.sd.us
Beth Windschitl, Senior Secretary   beth.windschitl@state.sd.us 
Board of  Pharmacy Website  www.pharmacy.sd.gov